| Product NDC: | 0143-9981 |
| Proprietary Name: | Amoxicillin and Clavulanate Potassium |
| Non Proprietary Name: | Amoxicillin and Clavulanate Potassium |
| Active Ingredient(s): | 200; 28.5 mg/5mL; mg/5mL & nbsp; Amoxicillin and Clavulanate Potassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0143-9981 |
| Labeler Name: | West-ward Pharmaceutical Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065191 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071201 |
| Package NDC: | 0143-9981-50 |
| Package Description: | 50 mL in 1 BOTTLE (0143-9981-50) |
| NDC Code | 0143-9981-50 |
| Proprietary Name | Amoxicillin and Clavulanate Potassium |
| Package Description | 50 mL in 1 BOTTLE (0143-9981-50) |
| Product NDC | 0143-9981 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Amoxicillin and Clavulanate Potassium |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20071201 |
| Marketing Category Name | ANDA |
| Labeler Name | West-ward Pharmaceutical Corp |
| Substance Name | AMOXICILLIN; CLAVULANIC ACID |
| Strength Number | 200; 28.5 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |